Head-to-Head Peptide Comparisons

Choose Semaglutide for established single-receptor GLP-1 research with the longest half-life in its class. Choose Tirzepatide when studying dual incretin pathway synergy for potentially greater metabolic effects.

Choose BPC 157 for GI-focused, localized tissue repair and angiogenesis research. Choose TB500 for systemic tissue repair, cell migration, and anti-inflammatory studies. Many researchers use both together for complementary healing pathways.

Choose Retatrutide for triple-receptor research exploring maximum metabolic impact including energy expenditure via glucagon receptor activation. Choose Tirzepatide for well-established dual-agonist protocols with more extensive clinical data.

Choose CJC-1295 with DAC for sustained, continuous GH elevation via GHRH receptor stimulation. Choose Ipamorelin for selective, pulsatile GH release via the ghrelin receptor without cortisol or prolactin side effects. They are frequently studied together for synergistic GH release.

Choose Epithalon for telomerase activation and telomere elongation research targeting replicative senescence. Choose NAD+ for sirtuin-dependent pathways, mitochondrial biogenesis, and cellular energy metabolism research. They target complementary aging mechanisms.

Choose Selank for anxiolytic and immune-modulation research via GABAergic pathways without sedation or dependence. Choose Semax for cognitive enhancement, memory consolidation, and BDNF/neurotrophin upregulation research.

Choose HGH for direct growth hormone supplementation research with precise dosing control. Choose Sermorelin for research that preserves the natural GH pulsatile axis and feedback mechanisms, at a lower cost per protocol.

Choose Melanotan I for selective MC1R photoprotection and melanogenesis research with fewer off-target effects. Choose Melanotan II for broader melanocortin research including sexual function (MC4R) and appetite suppression alongside tanning effects.

Choose GHRP-2 for maximum GH release potency with moderate appetite stimulation. Choose GHRP-6 when appetite stimulation via ghrelin pathways is a desired research variable, or for cardioprotection and gastric motility studies.

Choose MK-677 for oral delivery convenience and sustained 24-hour GH/IGF-1 elevation in research. Choose Ipamorelin for the most selective injectable GH release without cortisol or prolactin elevation, ideal for protocols requiring clean pulsatile GH patterns.